Sakar Healthcare Limited - Asset Resilience Ratio

Latest as of March 2026: 0.05%

Sakar Healthcare Limited (SAKAR) has an Asset Resilience Ratio of 0.05% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs2.17 Million

≈ $23.52K USD Cash + Short-term Investments

Total Assets

Rs4.81 Billion

≈ $52.02 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2026)

This chart shows how Sakar Healthcare Limited's Asset Resilience Ratio has changed over time. Check Sakar Healthcare Limited strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Sakar Healthcare Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sakar Healthcare Limited stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.17 Million	0.05%
Total Liquid Assets	Rs2.17 Million	0.05%

Asset Resilience Insights

Limited Liquidity: Sakar Healthcare Limited maintains only 0.05% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sakar Healthcare Limited Industry Peers by Asset Resilience Ratio

Compare Sakar Healthcare Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Sakar Healthcare Limited (2017–2026)

The table below shows the annual Asset Resilience Ratio data for Sakar Healthcare Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	0.05%	Rs2.17 Million ≈ $23.52K	Rs4.81 Billion ≈ $52.02 Million	-0.03pp
2025-03-31	0.07%	Rs3.09 Million ≈ $33.45K	Rs4.15 Billion ≈ $44.91 Million	+0.02pp
2024-03-31	0.05%	Rs2.08 Million ≈ $22.45K	Rs3.89 Billion ≈ $42.03 Million	-0.99pp
2023-03-31	1.05%	Rs35.23 Million ≈ $380.96K	Rs3.36 Billion ≈ $36.37 Million	-1.61pp
2022-03-31	2.65%	Rs71.06 Million ≈ $768.50K	Rs2.68 Billion ≈ $28.96 Million	-1.39pp
2021-03-31	4.04%	Rs71.88 Million ≈ $777.41K	Rs1.78 Billion ≈ $19.23 Million	+3.00pp
2020-03-31	1.04%	Rs12.01 Million ≈ $129.88K	Rs1.15 Billion ≈ $12.45 Million	+0.67pp
2019-03-31	0.37%	Rs3.67 Million ≈ $39.67K	Rs986.85 Million ≈ $10.67 Million	-0.08pp
2018-03-31	0.45%	Rs3.62 Million ≈ $39.18K	Rs811.00 Million ≈ $8.77 Million	-0.19pp
2017-03-31	0.64%	Rs4.52 Million ≈ $48.87K	Rs705.87 Million ≈ $7.63 Million	--

pp = percentage points

About Sakar Healthcare Limited

NSE:SAKAR India Drug Manufacturers - Specialty & Generic

Market Cap

$218.98 Million

Rs20.25 Billion INR

Market Cap Rank

#16177 Global

#845 in India

Share Price

Rs922.50

Change (1 day)

+4.21%

52-Week Range

Rs317.10 - Rs922.50

All Time High

Rs922.50